Concinnity Genetics transform the safety of gene therapies by designing novel control mechanisms using AI platform.
Concinnity Genetics has raised $3.8M in total funding. The most recent round was Seed. The last funding was announced in December 2024.
Concinnity Genetics's investors include Maven Capital Partners, Eos, Scottish Enterprise, Old College Capital.
Concinnity Genetics is headquartered in Edinburgh, United Kingdom.
Concinnity Genetics transform the safety of gene therapies by designing novel control mechanisms using AI platform.
Concinnity Genetics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Concinnity Genetics — Funding & Investors." VCBacked, December 16, 2024, https://www.vcbacked.co/company/concinnity-genetics. Accessed September 29, 2026.
VCBacked. (2024). Concinnity Genetics — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/concinnity-genetics
{{cite web |title=Concinnity Genetics — Funding & Investors |url=https://www.vcbacked.co/company/concinnity-genetics |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated